While Barrett’s esophagus itself does not cause symptoms, it can increase the risk of developing esophageal adenocarcinoma (EAC), a type of cancer.
Hightower’s teams worked tirelessly for a treatment for Barrett’s esophagus that could help individuals.
Barrett’s esophagus develops when the lining of the esophagus undergoes abnormal healing, transitioning from skin-like cells to cells resembling those found in the intestine. It is often a result of long-standing gastroesophageal reflux disease (GERD). Barrett’s esophagus can increase the risk of developing cancer.
Hightower Clinical conducted research on an investigational device to assess its effectiveness in screening for Barrett’s esophagus (BE) and esophageal adenocarcinoma (EAC) in high-risk patients. The study compared the investigational device’s performance with the screening method.
Not Recruiting
1
While Barrett’s esophagus itself does not cause symptoms, it can increase the risk of developing esophageal adenocarcinoma (EAC), a type of cancer.
Barrett’s esophagus typically does not cause noticeable symptoms. However, individuals may experience symptoms associated with gastroesophageal reflux disease (GERD), such as heartburn, regurgitation, chest pain, and difficulty swallowing.
Some trials offer compensation for time and travel, but this varies depending on the study.
Yes, all clinical trials have strict privacy protocols to protect your personal information.